PCN3- COST ANALYSIS OF SCHIZOPHRENIA TREATMENT IN GERMANY- A COMPARISON OF OLANZAPINE, RISPERIDONE, AND HALOPERIDOL USING A CLINICAL DECISION MODEL
Sep 1, 1999, 00:00 AM
10.1016/S1098-3015(10)75843-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)75843-5/fulltext
Section Title :
Section Order :
89
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75843-5&doi=10.1016/S1098-3015(10)75843-5